Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
cbdMD Inc last posted its earnings results on Tuesday, February 17th, 2026. The company reported $-0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.02. The company had revenue of 5.02 M for the quarter and had revenue of 19.19 M for the year. cbdMD Inc has generated $-1 earnings per share over the last year ($-1.09 diluted earnings per share) and currently has a price-to-earnings ratio of -3.51. cbdMD Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/17/2026 | Q1 2026 | -$0.06 | -$0.04 | 0.02 | $4.86 M | $5.02 M |
| 10/06/2025 | Q4 2025 | N/A | -$0.08 | N/A | $4.70 M | $4.72 M |
| 08/14/2025 | Q3 2025 | -$0.02 | -$0.21 | -0.19 | $5.30 M | $4.61 M |
| 05/15/2025 | Q2 2025 | -$1.60 | -$0.29 | 1.31 | $5.14 M | $4.75 M |
| 02/13/2025 | Q1 2025 | -$0.37 | -$0.22 | 0.15 | $5.19 M | $5.11 M |
| 01/27/2025 | Q4 2024 | N/A | -$0.27 | N/A | $4.81 M | $4.56 M |
| 08/14/2024 | Q3 2024 | -$0.62 | -$0.15 | 0.47 | $4.93 M | $5.17 M |
| 05/15/2024 | Q2 2024 | -$0.75 | -$1.35 | -0.6 | $5.40 M | $4.38 M |
| 02/13/2024 | Q1 2024 | -$0.74 | -$0.67 | 0.07 | N/A | $5.38 M |
| 01/26/2024 | Q4 2023 | -$0.74 | -$5.70 | -4.96 | N/A | $5.71 M |
| 08/10/2023 | Q3 2023 | -$21.60 | -$1.16 | 20.44 | N/A | $6.12 M |
| 05/15/2023 | Q2 2023 | -$28.80 | -$1.74 | 27.06 | N/A | $6.24 M |
| 02/13/2023 | Q1 2023 | -$15.75 | -$3.70 | 12.05 | N/A | $6.09 M |
| 12/15/2022 | Q4 2022 | -$1.35 | -$11.47 | -10.12 | N/A | $7.86 M |
| 08/11/2022 | Q3 2022 | -$2.25 | -$24.76 | -22.51 | N/A | $8.59 M |
| 05/13/2022 | Q2 2022 | -$4.05 | -$4.32 | -0.27 | N/A | $9.63 M |
| 02/10/2022 | Q1 2022 | -$11.53 | -$15.39 | -3.86 | N/A | $9.32 M |
| 12/17/2021 | Q4 2021 | N/A | -$3.41 | N/A | N/A | $9.79 M |
| 08/12/2021 | Q3 2021 | -$0.01 | $0.78 | 0.79 | N/A | $10.56 M |
| 05/12/2021 | Q2 2021 | -$10.81 | -$10.38 | 0.43 | N/A | $11.80 M |
In the previous quarter, cbdMD Inc (:YCBD) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.02.
The conference call for cbdMD Inc's latest earnings report can be listened to online.
The conference call transcript for cbdMD Inc's latest earnings report can be read online.
cbdMD Inc (:YCBD) has a recorded annual revenue of $19.19 M.
cbdMD Inc (:YCBD) has a recorded net income of $-2,040,902.cbdMD Inc has generated $-1.09 earnings per share over the last four quarters.
cbdMD Inc (:YCBD) has a price-to-earnings ratio of -3.51 and price/earnings-to-growth ratio is -0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED